Earnings Feed
Start Free
Home/Filings/4/A/0001209191-22-024405
4/A//SEC Filing

Portnoy Mark L. 4/A

Accession 0001209191-22-024405

CIK 0000862692other
View on SEC.govCompany Profile

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 4:00 PM ET

Size

19.8 KB

Accession

0001209191-22-024405

Insider Transaction Report

Form 4/AAmended
Period: 2022-04-08
CRYO CELL INTERNATIONAL INCCCEL
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
  • Disposition to Issuer

    Stock Option

    2021-12-22$12.27/sh−100,000$1,227,000→ 0 total
    Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying)
  • Award

    Stock Option

    2022-04-08$13.50/sh+20,000$270,000→ 20,000 total
    Exercise: $13.50From: 2022-12-22Exp: 2024-12-22→ Common Stock (20,000 underlying)
  • Award

    Stock Option

    2022-04-08$12.27/sh+100,000$1,227,000→ 100,000 total
    Exercise: $12.27From: 2022-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying)
  • Disposition to Issuer

    Stock Option

    2021-12-22$13.50/sh−20,000$270,000→ 0 total
    Exercise: $13.50From: 2021-12-22Exp: 2024-12-22→ Common Stock (20,000 underlying)
Holdings

  • Common Stock

    (indirect: By Partnership)
    71,529

  • Common Stock

    762,514

  • Stock Option

    Exercise: $7.92From: 2018-03-08Exp: 2028-03-08→ Common Stock (20,000 underlying)
    20,000

  • Stock Option

    Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying)
    20,000

  • Common Stock

    (indirect: By 401(k))
    42,266

  • Stock Option

    Exercise: $3.14From: 2016-04-15Exp: 2026-04-15→ Common Stock (59,459 underlying)
    59,459

  • Stock Option

    Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common Stock (22,222 underlying)
    22,222
Footnotes (6)
  • [F1]Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
  • [F2]Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.
  • [F3]On April 8, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer.
  • [F4]The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting.
  • [F5]One-third of the stock options will vest on December 22, 2022, one-third will vest on January 22, 2023 and one-third on January 22, 2024.
  • [F6]Stock options vest immediately when the price of the Company's stock reaches $25.00 per share during the seven-year option term.

Documents

1 file

Issuer

CRYO CELL INTERNATIONAL INC

CIK 0000862692

→
Entity typeother

Related Parties

1
  • filerCIK 0001529249

Filing Metadata

Form type
4/A
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:00 PM ET
Size
19.8 KB
View on SEC.gov